期刊文献+

氨甲环酸在婴幼儿心肺转流过程中的应用

The effects of tranexamic acid in pediatric extracorporeal circulation
下载PDF
导出
摘要 目的采用随机对照的实验方法,在心肺转流(CPB)过程中应用高、低两种剂量的氨甲环酸,研究其对婴幼儿先天性心脏病(简称先心病)术中、术后出血量、用血量以及凝血系统功能的影响,探讨婴幼儿ECC过程中的合理用药剂量及用药方法。方法随机选取紫绀型先天性心脏病患儿45例,按照氨甲环酸用药量分为低剂量组(A组,15例),高剂量组(B组,15例)和对照组(C组,15例,未用药);于相应时间点取血,监测凝血功能、血小板数目、肝肾功能,并记录患儿术后失血量、用血量等相关指标。结果 A组与B组和C组两组比较,关胸时间明显缩短、血浆纤维蛋白原含量明显减少、血小板破坏明显减少、术后失血及用血量减少;B组与C组比较,各项指标基本无明显差异。结论在婴幼儿心肺转流过程中应用氨甲环酸,可缩短关胸时间,减少血小板破坏,且以低剂量组作用更明显。 OBJECTIVE In this random control experiment,two dosages of tranexamic acid have been used in cardiopulmonary bypass to decrease bleeding and to reduce the need for transfusion: a low dosage(10 mg/kg),a high dosage(50 mg/kg).We are seeking to determine whether one dosage is superior to the another.To determine a low dosage(10 mg/kg) or a high dosage(50 mg/kg) tranexamic acid used in cardiopulmonary bypass(CPB) can effectively decrease bleeding and reduce the need for transfusion in this random control experiment.METHODS 45 children with cyanotic congenital heart disease were randomly assigned to three groups(15 cases in each group): Group A(received low dosage tranexamic acid),Group B(received high dosage tranexamic acid) and Group C(received low dosage sodium chloride).Blood samples were taken at three time-spots for coagulation studies,platelet count,liver and kidney function test.Also the amount of postoperative cumulative blood loss and transfusion of blood products were recorded.RESULTS Comparing with those in Group B and C,patients in Group A has the shortest sternal closure time,the least amount of fibrinogen,the most amount of platelet and less blood loss.But there is no significant difference between Group B and C.CONCLUSION The use of low dosage tranexamic acid in pediatric CPB is superior to short the sternal closure time and raise the amount of platelet.
出处 《中国体外循环杂志》 2010年第3期166-169,共4页 Chinese Journal of Extracorporeal Circulation
关键词 氨甲环酸 心肺转流 紫绀 先天性心脏病 血小板 Tranexamic acid Cardiopulmonary bypass Cyanotic Congenital heart disease Platelet
  • 相关文献

参考文献6

  • 1Chauhan S, Das SN, Bisoi A, et al. Comparison of epsilon aminocaproic acid and tranexamic acid in pediatric cardiac surgery [J]. J Cardiothorac Vasc Anesth,2004,18(2) :141 -143.
  • 2Fiechtner BK, Nuttall GA, Johnson ME, et al. Plasma tranexamic acid concentrations during cardiopulmonary bypass [ J ]. Anesth Analg,2001,92(5) :1131 - 1136.
  • 3岳军,杨静,邓硕曾.氨甲环酸与抑肽酶在小儿体外循环中对鸟苷一磷酸140影响的比较研究[J].中国基层医药,2005,12(10):1317-1318. 被引量:2
  • 4武婷,文其祥.氨甲环酸与抑肽酶对血液保护功能的对比研究[J].中国体外循环杂志,2005,3(1):10-13. 被引量:16
  • 5Jimenez JJ, Iribarren JL, Lorente L, et al. Tranexamic acid attenuates inflammatory response in cardiopulmonary bypass surgery through blockade of fibrinolysis : a case control study followed by a randomized double - blind controlled trial [ J ]. Crit Care, 2007,11 (6) :R117.
  • 6Shuhaiber JH, Goldsmith K, Large SR, et al. Does perioperative use of aprotinin reduce the rejection rate in heart transplant recipients[ J] ? Eur J Cardiothorac Surg, 2008, ; 33 ( 5 ) : 849 - 855.

二级参考文献19

  • 1王秋萍,左大鹏,鞠淑英,张学勤.心脑血管性疾病患者血浆D-二聚体的检测[J].临床检验杂志,1996,14(2):85-86. 被引量:19
  • 2[1]Davis R, Whittington R. Aprotinin: a review of its pharmacology and therapeutic efficacy in reducing blood loss associated with cardiac surgery [ J ]. Drugs. 1995,49:954 - 983.
  • 3[2]Karski JM,Teasdale S J, Norman P, et al. Prevention of bleeding after CPB with high - dose tranexamic acid: double - blind, randomized clinical trial[J]. J Thorac Cardiovasc Surg, 1995,110:835 - 842.
  • 4[3]Karski JM, Teesdale SJ, Norman P, et al. Prevention of bleeding after CPB with high - dose tranexamic acid: double - blind, randomized clinical trial[J]. J Thorac Cardiovasc Surg, 1995,110:835 - 842.
  • 5[4]Valter Casati, Davide Guzzon, Michele Oppizzi, et al. Tranexamic acid compared with high - dose aprotinin in primary elective heart operations: effects on perioperative bleeding and allogenic transfusions [ J ]. J Thorac Cardiovasc Surg, 2000,120 ( 3 ) :520 -527.
  • 6[5]Mannucci PM. Hemostatic drugs. N Engl J Med,1998,339:245- 253.
  • 7[6]Van Oeceren W. Aprotinin protects platelets against the initial effect of cardiopulmonary bypass[J]. J Thorac Cardiovasc Surg,1990,99: 788 - 797.
  • 8[7]Blauhut B, Harringer W, Bettelheim P, et al. Comparison of the effects of aprotinin and tranexamic acid on blood loss and related veriables after cardiopulmonary bypass [ J ]. J Thorac Cardiovasc Surg, 1994,108:1083 - 1091.
  • 9[8]Laupacis A, Fergusson D. Drugs to minimize perioperative blood loss in cardiac surgery: meta - analysis using perioperative blood transfusion as the outcome[ J ]. Anesthesia &Analgesia, 1997,85(6):1258 - 1267.
  • 10[11]Giansante C, Fiotti N, Cattin L, et al. Fibrinogen, D - dimer and Thrombin antithrombin complexes in a random population sample:relationships with other cardiovascular risk factor[ J ].Thromb Haemost, 1994,71 (5) :581 - 586.

共引文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部